Expertise in
10
conditions

Dr. Joseph Forstot

Internal Medicine
Office
1050 NW 15th St Ste 212A, 
Boca Raton, FL 
Expertise in
10
conditions
Office
1050 NW 15th St Ste 212A, 
Boca Raton, FL 

Overview

Joseph Forstot is an Internal Medicine provider practicing medicine in Boca Raton, Florida.

Dr. Forstot is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Osteoporosis, Postmenopausal Osteoporosis, Rheumatoid Arthritis (RA), and Calcium Pyrophosphate Arthritis.

He is actively involved in clinical research, co-authoring 2 peer reviewed articles and participating in 6 clinical trials.

Specialties

Internal Medicine

Licenses

Internal Medicine in FL

Hospital Affiliations

Boca Raton Regional Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Deseret Mutual Benefit Administrators
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Florida Blue
  • EPO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

Office
1050 NW 15th St Ste 212A, Boca Raton, FL 33486

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: July 22, 2025
Intervention Type: Drug
Study Drugs: Baricitinib, TNF Inhibitor
Study Phase: Phase 4
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
Enrollment Status: Terminated
Publish Date: November 30, 2023
Intervention Type: Drug, Biological
Study Drugs: Otilimab, Tofacitinib, csDMARDs
Study Phase: Phase 3
A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: October 12, 2023
Intervention Type: Drug
Study Drugs: Olokizumab, Methotrexate
Study Phase: Phase 3
A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy
A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy
Enrollment Status: Completed
Publish Date: September 21, 2023
Intervention Type: Drug
Study Phase: Phase 3
A Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Tumor Necrosis Factor Alpha (TNF-α) Inhibitor Therapy
A Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Tumor Necrosis Factor Alpha (TNF-α) Inhibitor Therapy
Enrollment Status: Completed
Publish Date: September 21, 2023
Intervention Type: Drug
Study Drug: Olokizumab
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
Enrollment Status: Terminated
Publish Date: January 30, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
View 5 Less Clinical Trials

2 Total Publications

Exploring the antiquity of rheumatoid arthritis: A case study from medieval Transylvania.
Exploring the antiquity of rheumatoid arthritis: A case study from medieval Transylvania.
Journal: International journal of paleopathology
Published: May 24, 2024
Similar Doctors
Expertise in
8
conditions
Dr. Seth Baum
Internal Medicine
Expertise in
8
conditions
Dr. Seth Baum
Internal Medicine

Office

7900 Glades Rd Ste 400, 
Boca Raton, FL 
 (4.7 miles away)
561-488-5535
Languages Spoken:
English
See accepted insurances

Seth Baum is an Internal Medicine provider practicing medicine in Boca Raton, Florida. Dr. Baum is highly rated in 8 conditions, according to our data. His clinical expertise encompasses High Cholesterol, Defective Apolipoprotein B-100, Homozygous Familial Hypercholesterolemia (HoFH), and Heterozygous Familial Hypercholesterolemia (HeFH).

Expertise in
27
conditions
Dr. Barry Davis
Internal Medicine
Expertise in
27
conditions
Dr. Barry Davis
Internal Medicine

Office

1601 Clint Moore Rd Ste 100, 
Boca Raton, FL 
 (2.7 miles away)
561-939-0200
Languages Spoken:
English
See accepted insurances

Barry Davis is an Internal Medicine provider practicing medicine in Boca Raton, Florida. Dr. Davis is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Bronchiectasis, Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), and Pneumonia.

Expertise in
62
conditions
Dr. James Chong
Internal Medicine
Expertise in
62
conditions
Dr. James Chong
Internal Medicine

Office

4675 Linton Blvd Ste 202, 
Delray Beach, FL 
 (1.6 miles away)
561-495-5700
Languages Spoken:
English
See accepted insurances
Offers Telehealth

James Chong is an Internal Medicine provider practicing medicine in Delray Beach, Florida. Dr. Chong is highly rated in 62 conditions, according to our data. His clinical expertise encompasses Angiodysplasia of the Colon, Barrett Esophagus, Gastroesophageal Reflux Disease (GERD), Endoscopy, and Gastrectomy.

Frequently Asked Questions about Dr. Joseph Forstot

How do I make an appointment with Dr. Joseph Forstot?

You can book an appointment with Dr. Joseph Forstot by calling their office at 561-368-5611. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Joseph Forstot a top-rated expert for Osteoporosis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Joseph Forstot is classified as an Distinguished expert for Osteoporosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Joseph Forstot specialize in?

While Dr. Joseph Forstot is a Internal Medicine, they have specific expertise in Osteoporosis, Postmenopausal Osteoporosis, and Rheumatoid Arthritis (RA). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.

Does Dr. Joseph Forstot participate in research or clinical trials?

Yes. Dr. Joseph Forstot has published 2 articles and abstracts on conditions like Osteoporosis. You can view a list of Dr. Joseph Forstot's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Joseph Forstot accept my insurance?

Dr. Joseph Forstot accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 561-368-5611 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Forstot's expertise for a condition
ConditionClose
    View All 8 Advanced Conditions
    View All 21 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile